المؤلفون: Jaeger-Ruckstuhl CA; Translational Sciences and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA. Electronic address: cjaeger@fredhutch.org., Lo Y; Translational Sciences and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA., Fulton E; Translational Sciences and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA., Waltner OG; Translational Sciences and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA., Shabaneh TB; Translational Sciences and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA., Simon S; Translational Sciences and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA., Muthuraman PV; Translational Sciences and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA., Correnti CE; Translational Sciences and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA., Newsom OJ; Human Biology Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA., Engstrom IA; Human Biology Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA., Kanaan SB; Translational Sciences and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA., Bhise SS; Translational Sciences and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA., Peralta JMC; Translational Sciences and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA., Ruff R; Translational Sciences and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA; Seattle Children's Hospital, Seattle, WA 98105, USA., Price JP; Translational Sciences and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA; Seattle Children's Hospital, Seattle, WA 98105, USA., Stull SM; Translational Sciences and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA., Stevens AR; Translational Sciences and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA., Bugos G; Translational Sciences and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA., Kluesner MG; Human Biology Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA., Voillet V; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA., Muhunthan V; Translational Sciences and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA., Morrish F; Translational Sciences and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA., Olson JM; Translational Sciences and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA; Seattle Children's Hospital, Seattle, WA 98105, USA., Gottardo R; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA; Department of Statistics, University of Washington, Seattle, WA 98195, USA; Swiss Institute of Bioinformatics, University of Lausanne and Lausanne University Hospital, Lausanne 1011, Switzerland., Sarthy JF; Seattle Children's Hospital, Seattle, WA 98105, USA; Basic Science Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA., Henikoff S; Basic Science Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA; Howard Hughes Medical Institute, Seattle, WA 98195, USA., Sullivan LB; Human Biology Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA., Furlan SN; Translational Sciences and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA; Seattle Children's Hospital, Seattle, WA 98105, USA., Riddell SR; Translational Sciences and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA; Department of Medicine, University of Washington, Seattle, WA 98195, USA. Electronic address: sriddell@fredhutch.org.

المصدر: Immunity [Immunity] 2024 Feb 13; Vol. 57 (2), pp. 287-302.e12.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Cell Press Country of Publication: United States NLM ID: 9432918 Publication Model: Print Cited Medium: Internet ISSN: 1097-4180 (Electronic) Linking ISSN: 10747613 NLM ISO Abbreviation: Immunity Subsets: MEDLINE

مواضيع طبية MeSH: CD28 Antigens*/metabolism , Gene Regulatory Networks*, TNF Receptor-Associated Factor 2/genetics ; TNF Receptor-Associated Factor 2/metabolism ; Signal Transduction ; Lymphocyte Activation ; Receptors, Antigen, T-Cell/metabolism ; Tumor Necrosis Factor Receptor Superfamily, Member 7/genetics ; Tumor Necrosis Factor Receptor Superfamily, Member 7/metabolism ; CD27 Ligand/genetics ; CD27 Ligand/metabolism ; CD8-Positive T-Lymphocytes

المؤلفون: Shabaneh TB; Immunotherapy Integrated Research Center, Fred Hutchinson Cancer Center, Seattle, Washington, USA., Stevens AR; Immunotherapy Integrated Research Center, Fred Hutchinson Cancer Center, Seattle, Washington, USA., Stull SM; Immunotherapy Integrated Research Center, Fred Hutchinson Cancer Center, Seattle, Washington, USA., Shimp KR; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA., Seaton BW; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA., Gad EA; Comparative Medicine, Fred Hutchinson Cancer Center, Seattle, Washington, USA., Jaeger-Ruckstuhl CA; Immunotherapy Integrated Research Center, Fred Hutchinson Cancer Center, Seattle, Washington, USA., Simon S; Immunotherapy Integrated Research Center, Fred Hutchinson Cancer Center, Seattle, Washington, USA., Koehne AL; Experimental Histopathology, Fred Hutchinson Cancer Center, Seattle, Washington, USA., Price JP; Molecular Design and Therapeutics, Fred Hutchinson Cancer Center, Seattle, Washington, USA., Olson JM; Molecular Design and Therapeutics, Fred Hutchinson Cancer Center, Seattle, Washington, USA., Hoffstrom BG; Antibody Technology, Fred Hutchinson Cancer Center, Seattle, Washington, USA., Jellyman D; Antibody Technology, Fred Hutchinson Cancer Center, Seattle, Washington, USA., Riddell SR; Immunotherapy Integrated Research Center, Fred Hutchinson Cancer Center, Seattle, Washington, USA sriddell@fredhutch.org.

المصدر: Journal for immunotherapy of cancer [J Immunother Cancer] 2024 Feb 07; Vol. 12 (2). Date of Electronic Publication: 2024 Feb 07.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101620585 Publication Model: Electronic Cited Medium: Internet ISSN: 2051-1426 (Electronic) Linking ISSN: 20511426 NLM ISO Abbreviation: J Immunother Cancer Subsets: MEDLINE

مواضيع طبية MeSH: T-Lymphocytes* , Immunotherapy, Adoptive*, Mice ; Humans ; Animals ; Xenograft Model Antitumor Assays ; Cell Line, Tumor ; Mice, Inbred Strains

المؤلفون: Leung I; Clinical Research Division, Fred Hutchinson Research Center, Seattle, WA., Templeton ML; Clinical Research Division, Fred Hutchinson Research Center, Seattle, WA., Lo Y; Clinical Research Division, Fred Hutchinson Research Center, Seattle, WA., Rajan A; Clinical Research Division, Fred Hutchinson Research Center, Seattle, WA., Stull SM; Clinical Research Division, Fred Hutchinson Research Center, Seattle, WA., Garrison SM; Clinical Research Division, Fred Hutchinson Research Center, Seattle, WA., Salter AI; Clinical Research Division, Fred Hutchinson Research Center, Seattle, WA., Smythe KS; Clinical Research Division, Fred Hutchinson Research Center, Seattle, WA., Correnti CE; Clinical Research Division, Fred Hutchinson Research Center, Seattle, WA., Srivastava S; Clinical Research Division, Fred Hutchinson Research Center, Seattle, WA., Yeung CCS; Clinical Research Division, Fred Hutchinson Research Center, Seattle, WA.; Department of Pathology, University of Washington, Seattle, WA., Riddell SR; Clinical Research Division, Fred Hutchinson Research Center, Seattle, WA.; School of Medicine, University of Washington, Seattle, WA.

المصدر: Blood advances [Blood Adv] 2023 Jun 27; Vol. 7 (12), pp. 2718-2730.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print Cited Medium: Internet ISSN: 2473-9537 (Electronic) Linking ISSN: 24739529 NLM ISO Abbreviation: Blood Adv Subsets: MEDLINE

مواضيع طبية MeSH: Receptors, Chimeric Antigen*/metabolism , Neoplasms*/metabolism, Humans ; T-Lymphocytes ; Immunotherapy, Adoptive ; B-Lymphocytes/metabolism ; Adaptor Proteins, Signal Transducing/metabolism

المؤلفون: Wilkens AB; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA.; Molecular and Cellular Biology, University of Washington, Seattle, WA., Fulton EC; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA., Pont MJ; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA., Cole GO; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA., Leung I; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA., Stull SM; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA., Hart MR; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA., Bernstein ID; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA., Furlan SN; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA., Riddell SR; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA.; Molecular and Cellular Biology, University of Washington, Seattle, WA.

المصدر: Blood [Blood] 2022 Nov 24; Vol. 140 (21), pp. 2261-2275.

نوع المنشور: Journal Article; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Elsevier Country of Publication: United States NLM ID: 7603509 Publication Model: Print Cited Medium: Internet ISSN: 1528-0020 (Electronic) Linking ISSN: 00064971 NLM ISO Abbreviation: Blood Subsets: MEDLINE

مواضيع طبية MeSH: Receptors, Chimeric Antigen* , Lymphoma*/drug therapy, Humans ; Mice ; Animals ; Immunotherapy, Adoptive ; CD4-Positive T-Lymphocytes ; Transcription Factors ; Receptors, Antigen, T-Cell ; Receptor, Notch1/genetics

المؤلفون: Shabaneh TB; Immunotherapy Integrated Research Center, Fred Hutchinson Cancer Center, Seattle, WA, United States., Moffett HF; Outpace Bio, Inc., Seattle, WA, United States., Stull SM; Immunotherapy Integrated Research Center, Fred Hutchinson Cancer Center, Seattle, WA, United States., Derezes T; Immunotherapy Integrated Research Center, Fred Hutchinson Cancer Center, Seattle, WA, United States., Tait LJ; Outpace Bio, Inc., Seattle, WA, United States., Park S; Lyell Immunopharma, Inc., Seattle, WA, United States., Riddell SR; Immunotherapy Integrated Research Center, Fred Hutchinson Cancer Center, Seattle, WA, United States., Lajoie MJ; Outpace Bio, Inc., Seattle, WA, United States.

المصدر: Frontiers in molecular medicine [Front Mol Med] 2022 Oct 11; Vol. 2, pp. 1026474. Date of Electronic Publication: 2022 Oct 11 (Print Publication: 2022).

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Frontiers Media S.A Country of Publication: Switzerland NLM ID: 9918402378306676 Publication Model: eCollection Cited Medium: Internet ISSN: 2674-0095 (Electronic) Linking ISSN: 26740095 NLM ISO Abbreviation: Front Mol Med Subsets: PubMed not MEDLINE

المؤلفون: Veatch JR; Clinical Research Division and Immunotherapy Integrated Research Center, Fred Hutchinson Cancer Research Center (FHCRC), Seattle, Washington, USA.; Department of Medicine, University of Washington, Seattle, Washington, USA., Singhi N; Clinical Research Division and Immunotherapy Integrated Research Center, Fred Hutchinson Cancer Research Center (FHCRC), Seattle, Washington, USA., Srivastava S; Clinical Research Division and Immunotherapy Integrated Research Center, Fred Hutchinson Cancer Research Center (FHCRC), Seattle, Washington, USA., Szeto JL; Clinical Research Division and Immunotherapy Integrated Research Center, Fred Hutchinson Cancer Research Center (FHCRC), Seattle, Washington, USA., Jesernig B; Clinical Research Division and Immunotherapy Integrated Research Center, Fred Hutchinson Cancer Research Center (FHCRC), Seattle, Washington, USA., Stull SM; Clinical Research Division and Immunotherapy Integrated Research Center, Fred Hutchinson Cancer Research Center (FHCRC), Seattle, Washington, USA., Fitzgibbon M; Public Health Sciences Division, FHCRC, Seattle, Washington, USA., Sarvothama M; Clinical Research Division and Immunotherapy Integrated Research Center, Fred Hutchinson Cancer Research Center (FHCRC), Seattle, Washington, USA., Yechan-Gunja S; Clinical Research Division and Immunotherapy Integrated Research Center, Fred Hutchinson Cancer Research Center (FHCRC), Seattle, Washington, USA., James SE; Memorial Sloan Kettering Cancer Center, New York, New York, USA., Riddell SR; Clinical Research Division and Immunotherapy Integrated Research Center, Fred Hutchinson Cancer Research Center (FHCRC), Seattle, Washington, USA.; Department of Medicine, University of Washington, Seattle, Washington, USA.

المصدر: The Journal of clinical investigation [J Clin Invest] 2021 Aug 16; Vol. 131 (16).

نوع المنشور: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: American Society for Clinical Investigation Country of Publication: United States NLM ID: 7802877 Publication Model: Print Cited Medium: Internet ISSN: 1558-8238 (Electronic) Linking ISSN: 00219738 NLM ISO Abbreviation: J Clin Invest Subsets: MEDLINE

مواضيع طبية MeSH: CD8-Positive T-Lymphocytes/*immunology , Cancer Vaccines/*therapeutic use, Adjuvants, Immunologic/administration & dosage ; Allografts ; Animals ; Antigen Presentation ; Antigens, Neoplasm/administration & dosage ; Autografts ; CD8-Positive T-Lymphocytes/transplantation ; Cancer Vaccines/immunology ; Cross Reactions/immunology ; Dendritic Cells/immunology ; Female ; Humans ; Immunologic Memory ; Immunotherapy, Adoptive ; Interleukin-12/immunology ; Lymphoid Tissue/immunology ; Male ; Melanoma, Experimental/immunology ; Melanoma, Experimental/therapy ; Mice ; Mice, Inbred C57BL ; Mice, Knockout ; Translational Research, Biomedical

المؤلفون: Mei L; Department of Chemistry and Biochemistry, University of Arizona, Tucson, Arizona 85721, United States., Moutet J; Department of Chemistry and Biochemistry, University of Arizona, Tucson, Arizona 85721, United States., Stull SM; Department of Chemistry and Biochemistry, University of Arizona, Tucson, Arizona 85721, United States., Gianetti TL; Department of Chemistry and Biochemistry, University of Arizona, Tucson, Arizona 85721, United States.

المصدر: The Journal of organic chemistry [J Org Chem] 2021 Aug 06; Vol. 86 (15), pp. 10640-10653. Date of Electronic Publication: 2021 Jul 13.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: American Chemical Society Country of Publication: United States NLM ID: 2985193R Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1520-6904 (Electronic) Linking ISSN: 00223263 NLM ISO Abbreviation: J Org Chem Subsets: MEDLINE

مواضيع طبية MeSH: Indoles* , Light*, Catalysis ; Methylation